NASDAQ$TASK

TaskUs Inc. · Q3 2025 earnings

Q3 2025 earnings · · Before market open · Investor relations

Briefing

TASK reported Q3 2025, net income of $31.4M, diluted EPS of $0.34.

For Q3 2025, TASK reported net income of $31.4M, diluted EPS of $0.34. Management discusses operating trends, liquidity, and strategic priorities as disclosed in the quarterly filing.

  • Net income $31.4M.
  • Diluted EPS $0.34.
  • TASK updated clinical, capital, or portfolio priorities in the filing.

Headline financials

Total Revenue

$299M

Previous: $255M+17.0%
EPS (adj)

$0.34

Previous: $0.37-8.1%
Revenue Growth YoY

17.0%

No prior period
Adj. EBITDA Margin

21.2%

No prior period
Net Income Margin

10.5%

No prior period
Adj. Net Income Margin

13.1%

No prior period
FCF Conversion

66.1%

No prior period
Adj. FCF Conversion

75.6%

No prior period
Capital Expenditures

-$43.8M

Previous: -$18.8M-132.5%
Net Income

$31.4M

Previous: $12.7M+147.1%
Operating Income

$37.9M

Previous: $24.2M+56.8%
Gross Profit

$113M

Previous: -$154M+173.7%

Revenue & EPS history

TaskUs · Revenue · Quarterly

$299M

Q3 2025+17%vs Q3 2024
Beat estimate in 14 of 15 quarters(93%)
ActualEstimate

Forward guidance

Management discusses TASK's outlook, capital deployment, and key risks as disclosed in the earnings materials and periodic report.

Tailwinds

  • TASK cited progress on strategic priorities in the quarterly filing.
  • Liquidity and balance sheet support continued operations and investment.

Headwinds

  • Macro, competitive, and regulatory factors may affect near-term results.
  • R&D, credit, or project timing can create quarter-to-quarter volatility.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

+3.2%

Avg return

Earnings day

+0.6%

Avg return

5 days after

+2.9%

Avg return

30 days after

65%

15 / 23 earnings

Positive

+29.1%

Q3 2022

Best reaction

-22.7%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+4.5%-8.3%-10.3%
Q4 2025+0.0%+2.7%-39.2%
Q3 2025+4.6%-5.3%-1.0%
Q1 2025+0.3%-0.8%-1.0%
Q4 2024-7.6%-13.4%-12.4%
Q3 2024+28.8%-0.1%+3.5%
Q2 2024+2.3%-11.3%-19.5%
Q1 2024+5.4%+12.2%+13.2%
Q4 2023+5.7%+4.0%-7.6%
Q3 2023+19.7%+25.2%+20.3%
Q2 2023-17.1%-13.6%-21.9%
Q1 2023+0.6%-6.8%+0.1%
Q4 2022-17.0%-11.9%-29.5%
Q3 2022+29.1%+31.3%+12.7%
Q2 2022-22.7%-29.4%-27.7%
Q1 2021-18.4%-3.1%-10.5%
Q1 2022-22.5%-12.1%-10.1%
Q4 2019+5.6%-3.4%+9.8%
Q4 2021+19.7%+10.3%+39.9%
Q3 2020-0.1%-7.6%-33.8%
Q3 2021+4.5%+4.4%-30.8%
Q4 2020+20.7%+22.4%+111.2%
Q2 2021+27.1%+29.1%+112.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro